Effect of exercise training on insulin-stimulated glucose disposal: A systematic review and meta-analysis of randomized controlled trials

Abstract

Background and Objective:

The effect of exercise training on whole-body insulin sensitivity has not been systematically summarized. We aimed to summarize the data from randomized controlled trials evaluating the effect of exercise training on insulin action, in adults.

Subjects:

MEDLINE, EMBASE, and CENTRAL databases were searched until January 2021. Randomized controlled trials lasting ≥ 4 weeks, including adults, and evaluating the effect of exercise on insulin-stimulated glucose disposal measured using the hyperinsulinemic euglycemic clamp, were included.

Methods:

Three reviewers extracted summary data from published trials. The primary outcome was insulin-stimulated glucose disposal. Standardized weighted mean differences (SMD) in glucose disposal between intervention and control were compared. The PEDro scale was used to assess risk of bias.

Results:

We included 25 trials (36 interventions, N=851). Exercise increased insulin-stimulated glucose disposal relative to control, SMD=0.52 (95% confidence interval [CI]: 0.39, 0.65; p<0.001; I²=47%) without significantly suppressing hepatic glucose production. In trials without isotopic tracers, exercise increased glucose disposal (SMD=0.63; 95% CI: 0.48, 0.77; p<0·001, I²=55%). In trials with isotopic tracers, exercise increased glucose disposal only when tracers were added to the exogenous glucose used for clamping (SMD=0.34; 95% CI: 0.03, 0·66, p=0·034. I²=0%). In a meta-regression model including aerobic exercise, weight change, and tracer technique, only percent weight change explained between trial heterogeneity (β=0.069; 95% CI: 0.005, 0.013). The PEDro rating indicated relatively low risk of bias (5.8 ± 0·22).

Conclusions:

Exercise training for at least four weeks significantly increases insulin-stimulated glucose disposal. Weight loss maximizes the effect and may be needed to improve hepatic insulin sensitivity. Differences in tracer methodology contribute to divergent outcomes and should be considered when assessing conclusions from research examining the effect of exercise on insulin action.

Primary Funding:

National Institute on Aging.

Registration:

PROSPERO (CRD42019124381).

INTRODUCTION

Skeletal muscle is the principal tissue for insulin-dependent glucose disposal from the blood, and a primary driver of whole-body glycemic control ¹. Under basal conditions, plasma free fatty acids are the primary substrate for skeletal muscle. Glucose or meal-stimulated insulin release suppresses adipose tissue lipolysis and plasma free fatty acids, which stimulates muscle glucose uptake and a switch to glucose as the primary fuel for muscle. People with obesity and type 2 diabetes typically have impaired insulin-stimulated muscle glucose oxidation and glycogen synthesis as a result of downregulation or degradation of insulin receptors and defects in post-receptor insulin signaling ^{2, 3}. Furthermore, insulin delivered into the portal vein is a major regulator of hepatic glucose production (HGP) and people with obesity, prediabetes, and type 2 diabetes have increased gluconeogenesis and an impairment in the capacity of insulin to suppress HGP ^{4, 5}.

Skeletal muscle is the primary site for insulin resistance in people with type 2 diabetes and improving insulin sensitivity in this tissue improves whole-body glucose homeostasis ⁶. Skeletal muscle responds to contraction or exercise with a rapid insulin-independent increase in glucose uptake during exercise and a transient insulin-stimulated pathway following exercise ^7-11. Exercise training leads to sustained increases in insulin sensitivity in healthy subjects and in people with type 2 diabetes.^12-14 Therefore, exercise training is part of the standard recommendations for treating and preventing obesity, type 2 diabetes, and related diseases that may be linked to insulin resistance ¹⁵.

The β-cell response to glucose and the sensitivity of body tissues to insulin are the key variables determining glucose homeostasis. Neither variable is held constant because of a feedback loop. The hyperinsulinemic euglycemic clamp test (hereinafter referred to as clamp) accounts for the simultaneous rather than sequential responses to glucose and insulin. The clamp offers a highly reproducible physiologic method for quantifying β-cell sensitivity to glucose and tissue sensitivity to insulin ¹⁶. Investigators who administer the clamp with isotopic tracer dilution techniques using the hot infusion protocol, which incorporates tracers into the exogenous glucose used for clamping ¹⁷, can measure the suppression of HGP.

The main tissues involved in insulin stimulated glucose disposal (hereinafter referred to as glucose disposal) are skeletal muscle, liver, and adipose tissue, and the impact of exercise training on adipose tissue insulin sensitivity has been summarized ¹⁸. Randomized controlled trials have examined the impact of exercise training on glucose disposal and suppression of HGP, but these randomized trials have not been systematically summarized. Furthermore, it is unknown whether factors such as exercise mode, duration, intensity, and weight loss influence glucose disposal in response to exercise. This systematic review and meta-analysis aimed to summarize the body of evidence from randomized controlled trials investigating the effect of exercise training on insulin action measured using the clamp. We hypothesized that exercise training would increase whole-body glucose disposal, which would be modified by program variables and clamp methodology.

METHODS

Data Sources and Searches

This systematic review followed the PRISMA reporting guidelines. The protocol was registered with the National Institute for Health Research International Prospective Register of Systematic Reviews (PROSPERO) with registration number, CRD42019124381. A search of three medical databases, including MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) was conducted by a research librarian from inception to January 5, 2021 (Supplemental Information Table 1). In addition, reference lists of publications eligible for full text review were searched to identify additional trials. Title, abstract, and full-text screening was conducted in duplicate by independent reviewers (CJR, and ACL or CJE) using Covidence systematic review software (Veritas Health Innovation, Melbourne, Australia). Reasons for exclusion were noted at each stage, and disagreements were resolved by consensus.

Study Selection

Eligible trials included randomized controlled trials in the adult population (aged ≥18 years), with an exercise intervention of at least four weeks, and that determined changes in glucose disposal using the clamp procedure. If there were multiple papers from one trial, only the paper that provided clamp-derived glucose disposal measures was chosen. All trials included a control arm where participants did not exercise. Trials that administered a concomitant intervention in the experimental group that was the same in the comparator group to enable isolation of the exercise effect, were also included. For our analyses, trials were excluded if the trial population included children, adolescents (<18 years), pregnant subjects, or did not report glucose disposal. Only trials published in English were included. Unpublished trials were not included.

Data Extraction and Quality Assessment

Data were independently extracted by one reviewer (ACL or CJE) and checked with another (CJR) using a pilot tested form. Disagreements were resolved by consensus or by a third reviewer (JCB). Data extracted from the eligible trials included population characteristics, location, exercise prescription (e.g., frequency, intensity, duration, type), clamp methodology, and overall changes from baseline to the end of the trial.

Exercise intensity was coded as a categorical effect including moderate, moderate to vigorous, or vigorous using the American College of Sports Medicine (ACSM) guidelines.¹⁹ Ratings were based on percent of maximal heart rate or heart rate reserve or maximum oxygen uptake (aerobic) or rate of perceived exertion or number of repetitions or percent of maximum (resistance). When insulin infusion rate was reported as mU/kg/min, it was converted into mU/m²/min by first converting the mean body weight into body surface area (BSA [m²] = 0.1173 * body weight [kg]^0.6466 ²⁰. The insulin infused reported in mU/kg/min * mean body weight (kg)/BSA (m²) was used to determine the insulin infusion in mU/m²/min.

The primary outcome was mean change in glucose disposal. Secondary outcomes included body weight, BMI, and maximal oxygen uptake (VO₂max) and it was determined a priori that these outcomes would be pursued if they were reported by at least 75% of trials. A critical appraisal of all trials was conducted using the Physiotherapy Evidence Database scale (PEDro scale). This checklist was developed to rate the methodological quality of RCTs and is validated for the reliability of a consensus rating from two or more assessors.²¹ PEDro scale scores range from 0 to 10 with higher scores indicating greater methodological and reporting quality ²². Data were independently assessed by one reviewer (ACL or CJE) and checked with another (CJR).

Data Synthesis and Analysis

To harmonize the various methods used for reporting glucose disposal, we used the standardized mean difference (SMD) to quantify the difference in glucose disposal from baseline to follow-up between the exercise and control groups. The SMD denotes the difference between the mean glucose values of the control and exercise groups, divided by the pooled standard deviation ²³. We present overall weighted mean effect sizes as both fixed- and random effects estimates. Values of 0.3, 0.5, and 0.8 for SMD correspond to small, medium, and large effects, respectively ²⁴. Potential heterogeneity was calculated as I^{2 25}. Begg’s and Egger’s tests were used to examine publication bias ²⁶. All statistical analyses were conducted using SAS (version 9.4, Cary, NC, USA).

Heterogeneity of changes in glucose disposal, the association between trial-level characteristics, and the magnitude of reduction in glucose disposal was assessed using a modified, weighted least squares regression ²⁷. Statistically significant regression analyses were integrated into a multiple fixed effects regression to determine which variables explain between-trial variance. Two-sided statistical significance was p < 0.05, and unless specifically stated, values are reported as SMD and 95% confidence intervals (CIs).

To determine the effect of program variables, we conducted sub-group analyses of trials by: demonstration of significant weight loss (p < 0.05), older adults (age > 60), use of tracers, exercise mode (Aerobic/Resistance/both), provision of standardized meals at least 2-3 days before the clamp, inclusion of patients with type 2 diabetes, and completion of the clamp at least 72 hours after the last exercise session (to determine the chronic effect of exercise). The criterion for sub-group analysis was that at least eight trials reported these data. If the analysis showed differing results within a subgroup, the variables were examined as covariates. In addition, percent weight change (% baseline body weight), insulin infusion rate, drop-out rate, age, baseline fasting glucose and insulin, and exercise training program variables such as number of minutes per session, frequency (days/week), duration of the intervention, overall intensity, and type were explored as covariates. Trials eligible for each synthesis were determined by tabulating the trial intervention characteristics and comparing against planned groups for each synthesis.

Exploratory Sub-analyses

Studies that use tracers report glucose disposal as glucose infusion rate + HGP, whereas studies that do not use tracers report glucose disposal as glucose infusion rate alone. Given the unexpected difference in the effect size between the studies that used tracers and those that did not use tracers, we conducted a sub-analysis to determine the effect of exercise on suppression of HGP during the clamp. If studies did not specifically report % suppression of HGP, it was calculated as the % difference between basal and clamp measures of HGP. As these analyses were unplanned, data should be interpreted as hypothesis-generating.

RESULTS

Description of Studies

Our search yielded 292 citations (Figure 1), of which 25 RCTs including 36 comparisons of exercise versus control (N=851) were eligible for inclusion in our analysis (Table 1). A list of excluded trials at full-text stage and the reasons for exclusion are provided in the Supplemental Information Table 2. Trials were conducted in North America (N=16) or Europe (N=9) and ranged in duration from four to 43 weeks.

Figure. 1.

PRISMA 2020 flow chart

Table 1.

Randomized trials of exercise versus control of at least four weeks duration in adults, included in our meta-analysis

First Author, Publish Year	Experiment group included in analysis	Comparison	Age Range	Duration	Frequency and Time	Intensity	Mode	Insulin infusion rate	% Retention Experiment: E; Control: C
Andersson 1998 [25]	Exercise + diet (adjusted to maintain body weight)	Sedentary + weight maintenance diet	30-55	10 (4 week standardized diet + 6 week exercise intervention)	7 times/ week, 30+ minutes	Moderate	Aerobic	56 mU/m2/min	E:90; C: 81.10
Arad 2015 [31]	Exercise	Usual Activity	20-40	14 weeks	3 times/week, 24 minutes	Vigorous	Aerobic	80 mU/m2/min	E: 64.3; C: 64.3
Baker 2010 [30]	Exercise	Balance and Flexibility	57-83	6 months	4 times/week, 45-60 minutes	Vigorous	Aerobic; Stretching in Comparison Group	40.8 mU/kg/min	E: 82.61; C: 81.8 ·
Bogardus 1984 [34]†	Exercise + Diet (450 kcal/m2 of initial body surface area, 60% carbohydrate25% protein, 15% fat)	Diet (450 Kcal/m2 of initial body surface area, 60% carbohydrate, 25% protein, 15% fat)	35-45	12 weeks	Supervised on 3 days/week of 60 minutes, advised to exercise on other days	Moderate to vigorous	Aerobic and Resistance Training	40 mU/m2/min	E: 90-100; C: 72-80
Brochu 2009 [33]	Exercise + Diet (caloric restriction of 624 kcals/day)	Diet (caloric restriction of 621 Kcals/day)	Post-meno-pausal women	6 months	3 non-consecutive days/week, time not reported	Moderate	Resistance Training	75 mU/m2/min	E:75; C: 79.80
Christensen 2013 [28]	Exercise + Placebo	Placebo	18-35	10 weeks	3 times/week, 40-45 minutes	Vigorous	Aerobic	24.5 mU/m2/min	E:100; C: 100
Coker 2006 [37]†	Group 1: Moderate Intensity Group 2: High Intensity	Usual exercise and diet	65-90	12 weeks	4-5 days/week, 45 minutes	Moderate(Moderate Intensity) and Vigorous (High intensity)	Aerobic	40 mU/m2/min	E: 92.8 (combining both groups); C: 100
Coker 2009 [42] †	Group 1: Exercise-induced weight loss; Group 2: Exercise without weight loss	Usual exercise and diet	50-80	12 weeks	Amount to expend weekly volume of exercise (1000-2500 kcal/week)	Moderate in both groups	Aerobic	44 mU/m2/min	Overall: 81 (not stated which groups lost to follow-up)
Cuff 2003 [41]	Group 1: Aerobic; Group 2: Aerobic + Resistance Training	Usual exercise and diet	Post-meno-pausal women	16 weeks	3 times/week, 75 minutes	Aerobic: Vigorous Resistance Training: Moderate	Aerobic and Resistance Training	40 mU/m2/min	E:100; C: 100
Davidson 2009 [46]	Group 1: Aerobic; Group 2: Resistance Training; Group 3: Aerobic + Resistance Training	Usual Exercise and Diet	60-80	6 months	3-5 times/week, 20-50 depending on experimental group	Moderate in all groups	Aerobic; Resistance Training; Aerobic and Resistance Training	40 mU/m2/min	E:83.3-94.3depending on group; C: 82·1
Dengel 1996 [36]	Exercise	Weekly Review of AHA Step 1 diet	> 45	10 months	3 times/week, 15 minutes at the start of the study and progressed to 40 minutes at end	Moderate to Vigorous	Aerobic	100 mU/m2/min	E:100; C:55 for clamp test
DiPietro 2006 [38]†	Group 1: Moderate Intensity; Group 2: High Intensity	Stretching	62-84	9 months	4 times/week, 55, 65, and 45 minutes for high, moderate and Control respectively	Moderate (Moderate Intensity) and Vigorous (High intensity)	Aerobic	10 mU/m2/min	92.6; Two dropped, groups not reported
Joseph 2001 [23]†	Exercise + Diet (Energy Restriction for Weight Loss)	Diet (Energy Restriction for Weight Loss)	55-79	4 weeks	3 times/week, 35 minutes low resistance warm up + Resistance Training	Moderate	Resistance Training	40 mU/m2/min	E:90.9; C:81.8
Marcus 2009 [22]	Eccentric Resistance Exercise	Usual Exercise and Diet	Post-meno-pausal women	12 weeks	3 times/week, 5-30 minutes depending on week	Moderate	Resistance Training	40 mU/m2/min	E:100; C: 100
Nordby 2012 [45]	Group 1: Exercise, Group 2: Exercise + Energy Increase	Usual Exercise and Diet	20-40	12 weeks	3-4 times/week, length varied depending on intensity	Vigorous in both groups	Aerobic	40 mU/m2/min	Exercise: 70.5; Exercise + Energy Increase: 92.3; C: 80
Otten 2018 [29]†	Exercise + Diet (Paleoliethic)	Diet (Paleoliethic) and standard care exercise recommendations	30-70	12 weeks	3 times/week, 60 minutes	Moderate	Aerobic and Resistance Training	40 mU/m2/min	E: 81; C: 81
Poehlman 2000 [40]	Group 1: Aerobic; Group 2: Resistance Training	Usual Exercise and Diet	18-35	28 weeks	3 times/week, 40-60 min Aerobic, Resistance Training not given	Vigorous (Aerobic) and Moderate (Resistance)	Aerobic or Resistance Training	40 mU/m2/min	Aerobic: 53.8; RT: 65.4; C: 76·9
Reichkendler 2014 [39]	Group 1: Moderate Dose; Group 2: High Dose	Usual Exercise and Diet	20-40	10-12 weeks	7 times/week, amount to expend 300 (moderate dose) or 600 (high dose) kcal/day	Moderate to vigorous in both groups	Aerobic	40 mU/m2/min	Moderate dose: 86; High dose: 82; C:94
Ross 2000 [44]	Group 1: Exercise-induced weight loss; Group 2: Exercise without weight loss	Weight maintenance	Mean age: 45 to 46 among the groups	12 weeks	7 times/week, expend 700 kcal (~63.6 minutes)	Moderate to vigorous in both groups	Aerobic	40 mU/m2/min	Exercise with Weight loss: 59.2; Exercise without weight loss: 45.2; C: 36.4
Ross 2004 [43]	Group 1: Exercise-induced weight loss; Group 2: Exercise without weight loss	Weight maintenance	Pre-meno-pausal women	14 week intervention + weight maintenance diet for 4-5 weeks prior to baseline visit	7 times/week, expend 500 kcal/day (~63-64 minutes)	Vigorous in both groups	Aerobic	40 mU/m2/min	Exercise with Weight loss: 73.9; Exercise without weight loss: 42.86; C:43.4
Shojaee-Moradie 2007 [26]†	Exercise	Usual Exercise and Diet	Mean age: 50 years	6 weeks	≥ 3 times/week, ≥ 20 minutes	Vigorous	Aerobic	64.5 mU/kg/min	E:100; C:100
Snel 2012 [32]†	Exercise + Diet (Very Low Calorie)	Diet (Very Low Calorie)	50-60, postmenopausal	16 weeks	Home average: 5.25 times/week, 35.25 minutes; Hospital: 1 time/week, 60 minutes	Vigorous	Aerobic	40 mU/m2/min	E:100; C:100
Stener-Victorin 2012 [27]	Exercise	Usual Exercise and Diet	18-38	16 weeks	≥ 3 times/week, ≥30 minutes	Moderate	Aerobic	0.12 U/kg/min‡	E:73.3; C:86.7
Wagner 2006 [24]	Acarbose + Exercise	Acarbose	45-60	12 weeks	3 times/week, 50 minutes	Moderate	Aerobic	1.0 mU/kg/min§	Not clear. E: 66.7 to 70: C:80.1 to 85
Yarasheski 2011 [35]†	Pioglitazone + Exercise	Pioglitazone	18-60	16 weeks	3 days/week, 1.5-2 hr/day	Vigorous	Aerobic and Resistance Training	30 mU/m2/min	E:86.4; C:90.9

^†Used stable isotope tracer technology in hyperinsulinemic euglycemic clamp test

^‡implausible value

^§body weight not provided (excluded from analysis of insulin infusion rate)

Fifteen trials evaluated one intervention ^28-42. Nine trials evaluated two interventions which included intensity (high and moderate) ^43-45, exercise type (aerobic and resistance) ^{46, 47} and with or without food compensation for energy expended through exercise ^48-51. One trial evaluated three interventions (aerobic, resistance, and the combination) ⁵². Five trials used the two-step clamp protocol: at the first step insulin was infused at a low dose (10-20mU/min/m²) and at the second step insulin was infused at a higher dose (40-100mU/m²/min) ^{32, 42, 44, 48}, except in one trial where the first step insulin infusion was 40mU/m²/min and the second step was 200mU/m²/min ²⁸ (Table 1). Eight trials including 10 interventions used intent-to-treat analytic strategies ^{28, 32, 33, 38, 43, 47, 52}, and one trial had a sample size exceeding 30 in each group ³⁹.

The baseline characteristics of the subjects are presented in Table 2. Eight trials specifically enrolled subjects with type 2 diabetes ^{30, 35, 36, 38, 40, 43, 47, 48} and the other trials included subjects with fasting or postprandial blood glucose concentrations in the normal to prediabetes range. Five trials ^{31, 32, 44, 45, 51} specifically included subjects who were in the overweight category (BMI 25-29.9 kg/m²), and two trials ^{34, 46} included subjects with BMI < 30 kg/m². The remaining trials included subjects with overweight, or obesity (BMI > 30 kg/m²).

Table 2.

Baseline characteristics of subjects. Values are the mean of the intervention means ± standard deviation

Variable	Number of Interventions	Experimental	Control
Age (years)	36	50.3 ± 16.1	50.9 ± 15.2
Body Weight (kg)	25	87.4 ± 1..0	87.6 ± 11.1
BMI (kg/m2)	34	29.4 ± 3.3	29.5 ± 3.9
Fasting Glucose mg/dL	27	103.8 ± 24.3	105.4 ± 29.0
Fasting Insulin mU/L	23	11.6 ± 5.1	11.1 ± 5.5

Quality (Risk of Bias) and Publication Bias Assessment

The mean PEDro score of the exercise interventions was 5.8 ± 1.08 (mean ± SD, Supplemental Information Table 3). The PEDro score was equal to or greater than 6.0 in 64% of trials indicating relatively high quality ²¹. Similar PEDro scores were observed for trials that provided data on body weight, BMI, and VO₂max. Few trials reported adherence to the intervention; however, five trials ^{37, 39, 46, 49, 50} reported more than 20% drop out rates. Trials did not specifically report adverse events but the reasons for withdrawal due to adverse events were reported in seven trials (Supplemental Information Table 4). Five trials including seven interventions ^{32, 38, 41, 43, 48}, used the hot infusion protocol to correct for perturbations in plasma glucose specific activity, by adding tracers to exogenous glucose used for clamping. Four trials including five interventions used the cold infusion protocol without adding tracers to exogenous glucose used for clamping ^{29, 35, 40, 44}. Seven trials reported the effect of exercise training on suppression of HGP ^{32, 35, 38, 40, 41, 44, 48}, and three of these trials used the cold infusion protocol ^{35, 40, 44}. In four studies the exercise was unsupervised ^{31, 33, 45, 51}, three studies used a combination of supervised and unsupervised exercise ^{36, 38, 40}, and in the remaining 18 studies exercise was supervised. All testing in the intervention and control groups was conducted in a controlled research setting. Begg’s test (p = 0.21), and Egger’s test (p = 0.19) identified no asymmetries in the effect size distribution suggestive of publication bias.

Association of Intervention with End Points

Exercise training was related to greater glucose disposal relative to control in both the fixed effects (SMD = 0.52; 95% CI: 0.39, 0.65; p < 0.001; I² = 47%) and random effects models (SMD = 0.55; 95% CI: 0.37, 0.73; p < 0.001, Figure 2). Furthermore, exercise training reduced body weight, (SMD = −0.40; 95% CI: −0·54, −0.26; p<0.001; I² = 46%), and BMI (SMD = −0.48; 95% CI: −0.62, −0.35; p < 0.001; I² = 41%), and increased VO₂max (SMD = 0.78; 95% CI: 0.64, 0·92; p < 0.001; I² = 74%).

Figure. 2.

Forest plot of the exercise-induced change in insulin-stimulated glucose disposal, stratified by use of isotopic tracer dilution techniques during the hyperinsulinemic euglycemic clamp.

In the sub-group analysis (Figure 3), trials that administered aerobic exercise (interventions: N = 26 aerobic alone, N = 5 resistance, and N = 5 aerobic and resistance) increased glucose disposal compared to other modes (aerobic, SMD = 0.68; 95% CI: 0.53, 0.84; p < 0.001; I² = 45%; other modes SMD = 0.21; 95% CI: −0.008, 0.42; p = 0.06; I² = 2.5%). Although exercise increased glucose disposal regardless of significant (p < 0.05) weight loss compared to control, reduction in body weight enhanced the effect (significant weight loss: SMD = 0.89; 95% CI: 0.69, 1.10; p < 0.001; I² = 58%; non-significant weight loss: SMD = 0.32; 95% CI: 0.16, 0.48; p < 0.001; I² = 0.5%). In trials that did not use tracers exercise increased glucose disposal (SMD = 0.63; 95% CI: 0.48, 0·77; p < 0.001; I² = 55%), whereas in trials that used tracers exercise did not increase glucose disposal (SMD = 0.22; 95% CI: −0.02, 0.47; p = 0.078; I² = 0%). The difference in glucose disposal between the trials that used and did not use tracers was moderate in magnitude (SMD = −0.46; p = 0.007, Figure 2).

Figure 3.

Forest plot of the exercise-induced change in insulin-stimulated glucose disposal in the sub-group analyses of trials by: exercise mode used, demonstration of significant weight loss (p < 0.05), and adoption of isotopic tracer dilution techniques.

When trials with tracers used the recommended hot infusion protocol, exercise increased glucose disposal versus control (SMD = 0.34; 95% CI: 0·03, 0·66; p = 0.034; I² = 0%). However, this effect size was smaller than trials that did not use tracers. In trials that used the cold infusion protocol, exercise did not increase glucose disposal (SMD = 0.04; 95% CI: −0.05, 0.43; p = 0.84; I² = 0%). A hypothetical example showing differences in the equation used to calculate glucose disposal in studies that used and did not use tracers is presented in Table 3.

Table 3.

Hypothetical calculation of glucose disposal

Studies without tracers	Studies with tracers
Glucose disposal = Glucose infusion	Glucose disposal = Glucose infusion + EGP
Baseline glucose disposal = 10	Baseline glucose disposal= 10 + 2 = 12
End of study glucose disposal = 37	End of study glucose disposal = 37 + 0.5 = 37.5
Effect size: End - Baseline = 37 −10 = 27	Effect size: End - Baseline = 37.5 - 12 = 25.5

EGP: Endogenous glucose production

Sub-group analysis of trials (N=17) that conducted the clamp at least 72 hours after the last exercise session showed that exercise increased glucose disposal, and the conduct of the clamp less than 72 hours after the last exercise session^{31, 34-36, 38, 41, 51} (one study did not provide the timing of the clamp after the last exercise session)³⁹ did not affect the outcome. Similarly, no differing results were obtained for the subgroup analysis by age, standardized meals, and inclusion of patients with type 2 diabetes. In the exploratory analysis of studies that reported suppression of HGP, exercise training did not influence HGP (SMD = −0.29; 95% CI: - 0.64, 0·06; p = 0.1; I² = 94%). Excluding trials that reported HGP but used the cold infusion protocol, did not improve the outcome.

When used as a covariate in the model, aerobic exercise influenced glucose disposal (β: −0.46, 95% CI: −0.81, −0.12). Furthermore, the use of tracers as a covariate in the model was a predictor of glucose disposal (β: 0.44; 95% CI: 0.07, 0.80). Except for percent weight change (β: 0.08; 95% CI: 0.02, 0.14), other covariates used in the analyses did not change the exercise-induced effect on glucose disposal. (Supplemental Information Table 5). In the multiple meta-regression model that included aerobic exercise, percent weight change, and use of tracers, only percent weight change explained the between-trial heterogeneity in the effect of exercise on glucose disposal (β: 0.069; 95% CI: 0.005, 0.013). Thus, each 5% loss of body weight was associated with SMD = 0.345.

DISCUSSION

This systematic review and meta-analysis demonstrated that in adults structured exercise training improves glucose disposal compared to control, and this gain extends beyond the effect of a single acute bout of exercise. The improvement in insulin action occurs regardless of weight loss but is enhanced by reductions in body weight. There was no improvement in hepatic insulin sensitivity. Similarly, the improvement in insulin action occurred regardless of whether or not the analysis included studies with subjects greater than 60 years of age or those with type 2 diabetes. Exercise frequency, intensity, duration, or type did not influence insulin action, but modality of exercise, specifically aerobic exercise, was an important predictor of the improvement in glucose disposal. The implications of these data are that exercise can favorably modulate a critical factor that drives metabolic disease in obesity, and weight loss enhances the effect, possibly through induction of mechanisms related to hepatic and adipose tissue insulin sensitivity.

During exercise, muscle glucose uptake increases but the process induced by muscle contractions is not dependent on insulin ⁵³. Muscle contractions do not activate the steps proximal to the receptor in the canonical insulin signaling cascade ⁵⁴. Following a single exercise bout, the mechanisms underlying improved insulin action involve a coordinated effect of insulin action on vasodilation, augmented capillary perfusion, and increased glucose transporter 4 (GLUT4) translocation to the muscle surface membrane ^{55, 56}. The molecular adaptations that regulate insulin sensitivity after one exercise bout lead to sustained elevations in insulin action with regular physical training ^57-60.

Our analysis including 36 interventions showed that in adults structured exercise training increases glucose disposal compared to control. The analysis predominantly included subjects with overweight and obesity, and we found that the cumulative effect of exercise training was not intensity- or length of exercise session-dependent. Despite large differences in training intensity and exercise time, moderate-intensity continuous training and high-intensity interval training show similar improvements in glucose disposal in adults with obesity after 12 weeks ⁶¹. Additionally, four weeks of moderate-intensity continuous training and high-intensity interval training were both effective in reducing intrahepatic lipids independent of changes in abdominal adiposity or body mass ⁶². Our analysis supports the findings from these studies ^{61, 62}, and from a meta-analysis showing that adipose tissue insulin resistance index reduces with aerobic exercise training but is not affected by exercise intensity ¹⁸.

One interesting finding was that glucose disposal was enhanced when studies were limited to exercise interventions reporting significant weight loss. Furthermore, meta regression showed that every 5% weight loss was associated with SMD = 0.345. Weight loss clearly improves insulin sensitivity but the effects in different organ systems have individual variability depending upon the duration and extent of the metabolic dysregulation. In general, insulin-mediated suppression of lipolysis in adipose tissue and suppression of HGP occur maximally at 5% to 8% weight loss ^{63, 64}. Insulin-mediated glucose disposal in skeletal muscle continues to increase with additional weight loss ⁶³. The effects of exercise on glucose disposal are primarily driven by skeletal muscle ⁶. We did not find a significant effect of exercise training on suppression of hepatic glucose production. Engin et al did not find an effect of exercise training on suppression of free fatty acids during the clamp except when accompanied by significant weight loss, in their meta-analysis summarizing the findings from intervention studies measuring the impact of exercise on adipose tissue insulin sensitivity ¹⁸. Sufficient weight loss is perhaps needed before the effect of exercise training on insulin sensitivity extends to the liver and adipose tissue.

The cold infusion protocol results in a marked underestimation of glucose disposal, generating biologically implausible negative values of HGP ¹⁷. Our subgroup analyses of trials using tracers showed that exercise increased glucose disposal compared to control, only when trials that followed the cold infusion protocol were excluded. However, the effect size was not as large as the trials that did not use tracers, which may in part be attributed to the methodology for evaluating glucose disposal. Glucose infusion accounts for the suppression of HGP from basal levels, that could arise from the intervention. For example, when insulin is infused at 40 mU/m²/min during the clamp it is unlikely to completely suppress HGP in adults with insulin resistance ^{65, 66}. If basal HGP is 2 mg/kg/min and the insulin infusion results in suppression of HGP to 1 mg/kg/min without an increase in glucose disposal, glucose infusion at 1 mg/kg/min would be needed to maintain euglycemia. If glucose disposal also increased by 1 mg/kg/min then glucose infusion would need to be 2 mg/kg/min. Therefore, glucose infusion = Δglucose disposal + ΔHGP. The trials that do not use tracers report glucose infusion which accounts for changes in hepatic insulin action without adding HGP which is expected to reduce at the end of an intervention (Table 3). Since glucose infusion = Δglucose disposal + ΔHGP, our analysis raises the question as to whether adding HGP to glucose infusion is necessary to calculate the overall effect of the intervention on insulin action. This anomaly in the gold standard for measuring insulin action where a less comprehensive method provides a more intuitive result, warrants resolution.

This review is the first to summarize findings relating to the effect of exercise training on glucose disposal. We were also able to synthesize the findings on hepatic insulin sensitivity assessed as insulin-mediated suppression of HGP. A key strength of this review is that we evaluated studies that used the gold standard technique for assessing insulin action. Given the controlled settings for conduct of the trials, the evidence supporting the effect of exercise training on insulin action, has high certainty. However, some considerations are noteworthy. In studies included in our meta-analysis, disparate methods were adopted in the administration of the clamp particularly in the use of tracers. Trials included in our analysis used an array of measures to report glucose disposal, such as per unit of body weight or per unit of fat free mass/skeletal muscle, or normalized to blood insulin concentrations, which made comparison between trials difficult. Therefore, we chose to focus on the SMD, and the statistical interpretation of the association between exercise and insulin action. Furthermore, variables such as the timing of the test following the last exercise bout and insulin infusion rate were not standardized. Lastly, we noted some consistent methodological weaknesses throughout the literature, such as small sample sizes, poor reporting of both adverse events and compliance with the intervention, and failure to follow intent-to-treat analytic strategies. However, there was no evidence of publication bias and overall, the trials were of high quality which facilitated a fair interpretation of our results.

In conclusion, exercise for at least four weeks is associated with improved insulin action in adults, compared to control. Since the exercise-stimulated increase in glucose disposal largely occurs in skeletal muscle, sufficient weight loss may be necessary before the effects of exercise extend to the liver and adipose tissue. While aerobic exercise is an important predictor of the improvement in insulin action, the duration and intensity of exercise do not influence the effect of exercise training on glucose disposal. Distinct methods produce distinct results, which is important for the field to recognize when designing and interpreting trials using the clamp. Therefore, our results highlight the need for evaluating and harmonizing methods for the clamp to enable a better understanding of the effects of exercise on insulin action.

DATA AVAILABILITY

The protocol for the study (CRD42019124381) is publicly available at: https://www.crd.york.ac.uk/prospero/ The datasets generated and analyzed during the current study are not publicly available but are available from the corresponding author on reasonable request